LNX1 assists the tumor-suppressive function of LDOC1 by mediating the targeted degradation of activated JAK2 (pJAK2), and resultantly, interferes in the IL-6/JAK2/STAT3 signaling axis [32]. The gene discussed is LNX1; the disease is neoplasm.